Sector Chart Akari Therapeutics, Plc

Equities

AKTX

US00972G2075

Market Closed - Nasdaq 04:30:00 2024-05-07 pm EDT 5-day change 1st Jan Change
1.45 USD +8.21% Intraday chart for Akari Therapeutics, Plc -5.84% -53.53%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
11.49M - - - - -
107B
106B
23.47B -
21.9B -
18.77B
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW